USA - NASDAQ:CSBR - US15870P3073 - Common Stock
We assign a fundamental rating of 5 out of 10 to CSBR. CSBR was compared to 56 industry peers in the Life Sciences Tools & Services industry. CSBR has a medium profitability rating, but doesn't score so well on its financial health evaluation. CSBR has a correct valuation and a medium growth rate.
Industry Rank | Sector Rank | ||
---|---|---|---|
ROA | 9.66% | ||
ROE | 84.15% | ||
ROIC | 30.3% |
Industry Rank | Sector Rank | ||
---|---|---|---|
OM | 5.29% | ||
PM (TTM) | 5.19% | ||
GM | 48.47% |
Industry Rank | Sector Rank | ||
---|---|---|---|
Debt/Equity | 0.02 | ||
Debt/FCF | 0.03 | ||
Altman-Z | 0.45 |
Industry Rank | Sector Rank | ||
---|---|---|---|
Current Ratio | 0.93 | ||
Quick Ratio | 0.93 |
Industry Rank | Sector Rank | ||
---|---|---|---|
PE | 18.02 | ||
Fwd PE | 42.4 |
Industry Rank | Sector Rank | ||
---|---|---|---|
P/FCF | 12.42 | ||
EV/EBITDA | 17.62 |
Industry Rank | Sector Rank | ||
---|---|---|---|
Dividend Yield | N/A |
NASDAQ:CSBR (10/17/2025, 8:04:22 PM)
6.487
-0.07 (-1.11%)
Industry Rank | Sector Rank | ||
---|---|---|---|
Dividend Yield | N/A |
Industry Rank | Sector Rank | ||
---|---|---|---|
PE | 18.02 | ||
Fwd PE | 42.4 | ||
P/S | 1.57 | ||
P/FCF | 12.42 | ||
P/OCF | 11.72 | ||
P/B | 25.5 | ||
P/tB | 28.19 | ||
EV/EBITDA | 17.62 |
Industry Rank | Sector Rank | ||
---|---|---|---|
ROA | 9.66% | ||
ROE | 84.15% | ||
ROCE | 38.35% | ||
ROIC | 30.3% | ||
ROICexc | N/A | ||
ROICexgc | N/A | ||
OM | 5.29% | ||
PM (TTM) | 5.19% | ||
GM | 48.47% | ||
FCFM | 12.66% |
Industry Rank | Sector Rank | ||
---|---|---|---|
Debt/Equity | 0.02 | ||
Debt/FCF | 0.03 | ||
Debt/EBITDA | 0.01 | ||
Cap/Depr | 28.08% | ||
Cap/Sales | 0.76% | ||
Interest Coverage | 250 | ||
Cash Conversion | 167.47% | ||
Profit Quality | 243.9% | ||
Current Ratio | 0.93 | ||
Quick Ratio | 0.93 | ||
Altman-Z | 0.45 |